LabCompass

Rafat Abonour

Medicine · Indiana University

OpenAlex ORCID
Multiple Myeloma Research and TreatmentsProtein Degradation and InhibitorsPeptidase Inhibition and AnalysisCancer Treatment and PharmacologyHematopoietic Stem Cell Transplantation

Publications

434

Citations

7,844

Est. group size

—

Recurring co-author estimate

Active years

38

Publishing since 1989

Research summary
AI-generated

Rafat Abonour studies multiple myeloma, a cancer of plasma cells in the bone marrow, focusing on how to treat it and improve patient outcomes. Much of the work evaluates newer therapies such as CAR T-cell treatments, antibody-based drugs, and stem cell transplant strategies, often using real-world patient registries and clinical trials. Some research also examines earlier or related blood conditions and uses tools like artificial intelligence and genomic analysis to guide treatment.

Multiple myeloma treatmentCAR T-cell and immunotherapy (e.g., ide-cel, teclistamab)Real-world outcomes and patient registriesStem cell transplantationMinimal residual disease and disease monitoring

Publication activity has been high and generally growing over the past decade, with a notable spike in 2023 and continued strong output averaging over 30 papers per year in recent years.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 32.4/year recently
2017: 20 publications172018: 17 publications182019: 24 publications192020: 17 publications202021: 15 publications212022: 26 publications222023: 74 publications74232024: 24 publications242025: 34 publications252026: 4 publications26
Recent publications
Publishes in
  • Blood×45
  • Clinical Lymphoma Myeloma & Leukemia×34
  • Journal of Clinical Oncology×30
  • HemaSphere×5
  • Biology of Blood and Marrow Transplantation×5

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile